Clinical Evaluation of Coronary Artery Fistula.
- Author:
Sak LEE
1
;
Young Hwan PARK
;
Han Ki PARK
;
Sang Hyun LIM
;
You Sun HONG
;
Byung Chul CHANG
;
Meyun Shick KANG
;
Bum Koo CHO
Author Information
1. Department of Thoracic and Cardiovascular Surgery, Yonsei University College of Medicine. yhpark@yumc.yonsei.ac.kr
- Publication Type:Original Article
- Keywords:
Coronary artery fistula;
Congenital heart disease (CHD);
Fistula
- MeSH:
Chest Pain;
Coronary Vessels*;
Dyspnea;
Fatigue;
Female;
Fistula*;
Follow-Up Studies;
Heart Diseases;
Heart Septal Defects, Atrial;
Heart Valve Diseases;
Humans;
Hypertension;
Mortality;
Syncope
- From:The Korean Journal of Thoracic and Cardiovascular Surgery
2005;38(10):699-704
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Coronary artery fistula is rare congenital anomaly, which account for 0.27~0.40% of all congenital heart diseases. We report the clinical observations of 45 patients with coronary artery fistula. MATERIAL AND METHOD: We reviewed all patients presented with or without symptoms of coronary artery fistula between 1987 and 2004. Age ranged from 1 to 83 years. Twenty-six patients were female. The patients were divided into 2 groups according to the presenting symptoms. Twelve patients were in group A (asymptomatic) and 33 patients in group B (symptomatic). The most common clinical presentation in group B was angina (18) followed by dyspnea (7), atypical chest pain (5), syncope (1), fatigue (1), and palpitation (1). Twenty-five patients were associated with other cardiac diseases, which were atrial septal defect (4), coronary artery occlusive disease (6), hypertension (12), and valvular heart disease (2). RESULT: Patients were followed-up for a mean period of 64.8+/-62.7 months. There was no complication related to coronary artery fistula during the follow-up period in both group. There was no mortality related to coronary artery fistula. CONCLUSION: In symptomatic patients, early surgical treatment is recommended considering the low perioperative morbidity. In asymptomatic patients receiving medical treatment, close follow up may be necessary.
